HealthScienceTechnologyWorld

Global Erectile Dysfunction Drug Market || keyplayers Pfizer Inc., Bayer AG, Eli Lily & Co., DONG-A PHARM

Erectile dysfunction (ED), is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction or impotence, can have psychological consequences as it can be tied to relationship difficulties and self-image. ED is more common among the geriatric population, and there has been a rise in the demand for ED drugs among this population which has led to an increase in the global erectile dysfuntion drug market.

The major driving factor for erectile dysfunction is – the changing lifestyle and eating habits. Further, increasing geriatric population also boost the global erectile dysfunction market. Increasing awareness related to ED due to advertisements for the treatment of ED is expected to drive the growth of the target market during the forecast period.

Furthermore, generic drugs are the rising opportunity for this market. As the patent of Viagra drug is about to expire in 2020, the manufactures are showing keen interest in development of generic Viagra. Moreover, novel drug delivery techniques can also potentiate the target market growth. However, major drugs for erectile dysfunction have lost their patent in year 2017 and 2018, and went generic in market has declined the growth market.

Request free sample:-https://www.prophecymarketinsights.com/market_insight/Insight/request-discount/905

keyplayers

On the basis of region erectile dysfunctioning drug market is sub-segmented into North America, Latin America, Europe, Asia Pacific Middle, East and Africa.  North America is expected to dominate the global market for erectile dysfunction (ED) drugs followed by Europe and Asia Pacific. This can be attributed to increased awareness, the growing research and development activities. The key operators of the global erectile dysfunction drugs market are Pfizer Inc., Bayer AG, Eli Lily & Co., DONG-A PHARM, Apricus Biosciences Inc., Vivus, Inc., Meda AB, SK chemicals, Cristalia Produtos Quimicos Farmaceuticos Ltda., Teva Pharmaceutical Industries Ltd. The manufactures are involved in research and development for new molecules and drug in clinical trials, which is expected to boost the global erectile dysfunction drugs market in the near future.

 

Contact Us:

Mr. Alex (Sales Manager)

Prophecy Market Insights

Phone: +1 860 531 2701

+91 777 504 9802
Email: sales@prophecymarketinsights.com

Back to top button